Loading...
Header Logo
Keywords
Last Name
Institution

Peter N Johnson

TitleProf,Asoc
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentPharmacy Clinical & Admin Sci
Address1110 N Stonewall Ave
Oklahoma City OK 73117-1200
Phone405/271-2730
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Jones AN, Miller JL, Neely S, Ibach BW, Hagemann TM, Golding CL, Lewis TV, Peek LA, Johnson PN. Prevalence of Unrounded Medication Doses and Associated Factors Among Hospitalized Pediatric Patients. J Pediatr Pharmacol Ther. 2017 Jul-Aug; 22(4):286-292. PMID: 28943824.
      View in: PubMed
    2. Duncan-Azadi CR, Johnson PN, Gormley A. Case Report of Midazolam Withdrawal-Induced Catatonia in a 9-Year-Old Patient. A A Case Rep. 2017 May 01; 8(9):242-245. PMID: 28181946.
      View in: PubMed
    3. Johnson PN, Nguyen A, Neely SB, Johnson M. Intramuscular Lorazepam for Status Epilepticus in Children With Complex Medical and Physical Disabilities. Ann Pharmacother. 2017 Aug; 51(8):656-662. PMID: 28438026.
      View in: PubMed
    4. Hughes KM, Johnson PN, Anderson MP, Sekar KC, Welliver RC, Miller JL. Comparison of Amikacin Pharmacokinetics in Neonates Following Implementation of a New Dosage Protocol. J Pediatr Pharmacol Ther. 2017 Jan-Feb; 22(1):33-40. PMID: 28337079.
      View in: PubMed
    5. Capino AC, Miller JL, Johnson PN. Clonidine for Sedation and Analgesia and Withdrawal in Critically Ill Infants and Children. Pharmacotherapy. 2016 Dec; 36(12):1290-1299. PMID: 27779775.
      View in: PubMed
    6. Johnson PN, Miller JL, Hagemann TM, Moffett BS. Assessment of inpatient admissions and top 25 medications for obese pediatric patients at two academic hospitals. Am J Health Syst Pharm. 2016 Aug 15; 73(16):1243-9. PMID: 27354039.
      View in: PubMed
    7. Johnson PN, Miller JL, Ranallo C. Dosing of Vasopressin in Critically Ill Children: Implications for Medication Safety. Pediatr Crit Care Med. 2016 Mar; 17(3):277-8. PMID: 26945208.
      View in: PubMed
    8. Golding CL, Miller JL, Gessouroun MR, Johnson PN. Ketamine Continuous Infusions in Critically Ill Infants and Children. Ann Pharmacother. 2016 Mar; 50(3):234-41. PMID: 26783355.
      View in: PubMed
    9. Benefield EC, Hagemann TM, Allen HC, Farmer K, Burton ME, Chavez-Bueno S, Johnson PN. Vancomycin Dosing and Pharmacokinetics in Postoperative Pediatric Cardiothoracic Surgery Patients. J Pediatr Pharmacol Ther. 2016 Jan-Feb; 21(1):66-74. PMID: 26997930; PMCID: PMC4778698.
    10. Thomas A, Miller JL, Couloures K, Johnson PN. Non-Intravenous Sedatives and Analgesics for Procedural Sedation for Imaging Procedures in Pediatric Patients. J Pediatr Pharmacol Ther. 2015 Nov-Dec; 20(6):418-30. PMID: 26766932; PMCID: PMC4708952.
    11. Boucher EA, Burke MM, Johnson PN, Klein KC, Miller JL. Minimum Requirements for Core Competency in Pediatric Pharmacy Practice. J Pediatr Pharmacol Ther. 2015 Nov-Dec; 20(6):481-4. PMID: 26766938; PMCID: PMC4708958.
    12. Ibach BW, Loeber C, Shukry M, Hagemann TM, Harrison D, Johnson PN. Duration of intrathecal morphine effect in children with idiopathic scoliosis undergoing posterior spinal fusion. J Opioid Manag. 2015 Jul-Aug; 11(4):295-303. PMID: 26312956.
      View in: PubMed
    13. Miller MM, Burton ME, Johnson PN, Miller JL. "Once-daily" versus "extended-interval" administration of aminoglycosides in neonates: need for standard terminology. Am J Health Syst Pharm. 2014 Dec 15; 71(24):2108-9. PMID: 25465576.
      View in: PubMed
    14. Miller MM, Johnson PN, Hagemann TM, Carter SM, Miller JL. Pseudohyperphosphatemia in children treated with liposomal amphotericin B. Am J Health Syst Pharm. 2014 Sep 01; 71(17):1462-8. PMID: 25147170.
      View in: PubMed
    15. Miller JL, Thomas AN, Johnson PN. Use of continuous-infusion loop diuretics in critically ill children. Pharmacotherapy. 2014 Aug; 34(8):858-67. PMID: 24897942.
      View in: PubMed
    16. Miller JL, Schaefer J, Tam M, Harrison DL, Johnson PN. Ethacrynic Acid continuous infusions in critically ill pediatric patients. J Pediatr Pharmacol Ther. 2014 Jan; 19(1):49-55. PMID: 24782692; PMCID: PMC3998969.
    17. Lammers EM, Johnson PN, Ernst KD, Hagemann TM, Lawrence SM, Williams PK, Anderson MP, Miller JL. Association of fentanyl with neurodevelopmental outcomes in very-low-birth-weight infants. Ann Pharmacother. 2014 Mar; 48(3):335-42. PMID: 24311724.
      View in: PubMed
    18. Johnson PN, Miller JL, Hagemann TM, Castro C, Harrison D. External validation of the medication taper complexity score for methadone tapers in children with opioid abstinence syndrome. Ann Pharmacother. 2014 Feb; 48(2):187-95. PMID: 24259650.
      View in: PubMed
    19. Johnson PN, Benefield EC, Bui PY, Marlar RA, Gessouroun MR. Fondaparinux in an obese child with heparin-induced thrombocytopenia and a history of renal failure. J Pediatr Pharmacol Ther. 2013 Oct; 18(4):303-10. PMID: 24719591; PMCID: PMC3979053.
    20. Johnson PN, Benefield EC, Bui PY, Gausman JN, Marlar RA, Gessouroun MR. Fondaparinux Monitoring: Need for a Local Fondaparinux-Calibrated Anti-F actor Xa Assay. J Pediatr Pharmacol Ther. 2013 Oct; 18(4):318-9. PMID: 24719594; PMCID: PMC3979056.
    21. Andrews MG, Johnson PN, Lammers EM, Harrison DL, Miller JL. Acetazolamide in critically ill neonates and children with metabolic alkalosis. Ann Pharmacother. 2013 Sep; 47(9):1130-5. PMID: 24259727.
      View in: PubMed
    22. Johnson PN, Miller JL, Hagemann TM. Sedation and analgesia in critically ill children. AACN Adv Crit Care. 2012 Oct-Dec; 23(4):415-34; quiz 435-6. PMID: 23095967.
      View in: PubMed
    23. Bulkley CF, Johnson PN, Henry E, Harrison D, Lewis TV, Miller JL. Bumetanide continuous-infusion dosing in critically ill pediatric patients. Am J Health Syst Pharm. 2012 Sep 01; 69(17):1458, 1460-1. PMID: 22899737.
      View in: PubMed
    24. Johnson PN, Boyles KA, Miller JL. Selection of the initial methadone regimen for the management of iatrogenic opioid abstinence syndrome in critically ill children. Pharmacotherapy. 2012 Feb; 32(2):148-57. PMID: 22392424.
      View in: PubMed
    25. Johnson PN, Harrison DL, Castro CH, Miller JL. A pilot study assessing the frequency and complexity of methadone tapers for opioid abstinence syndrome in children discharged to home. Res Social Adm Pharm. 2012 Sep-Oct; 8(5):455-63. PMID: 22222345.
      View in: PubMed
    26. Miller M, Miller JL, Hagemann TM, Harrison D, Chavez-Bueno S, Johnson PN. Vancomycin dosage in overweight and obese children. Am J Health Syst Pharm. 2011 Nov 01; 68(21):2062-8. PMID: 22011985.
      View in: PubMed
    27. Johnson PN, Miller J, Gormley AK. Continuous-infusion neuromuscular blocking agents in critically ill neonates and children. Pharmacotherapy. 2011 Jun; 31(6):609-20. PMID: 21923445.
      View in: PubMed
    28. Lewis TV, Johnson PN, Nebbia AM, Dunlap M. Increased enoxaparin dosing is required for obese children. Pediatrics. 2011 Mar; 127(3):e787-90. PMID: 21321026.
      View in: PubMed
    29. Gish EC, Harrison D, Gormley AK, Johnson PN. Dosing evaluation of continuous intravenous fentanyl infusions in overweight children: a pilot study. J Pediatr Pharmacol Ther. 2011 Jan; 16(1):39-46. PMID: 22477823; PMCID: PMC3136232.
    30. Johnson PN, Harrison D, Allen C. Utility of transdermal fentanyl for prevention of iatrogenic opioid abstinence syndrome in children. J Opioid Manag. 2010 Mar-Apr; 6(2):117-24. PMID: 20481176.
      View in: PubMed
    31. Weant KA, Johnson PN, Bowers RC, Armitstead JA. Evidence-based, multidisciplinary approach to the development of a crotalidae polyvalent antivenin (CroFab) protocol at a university hospital. Ann Pharmacother. 2010 Mar; 44(3):447-55. PMID: 20124465.
      View in: PubMed
    32. Honey BL, Harrison DL, Gormley AK, Johnson PN. Evaluation of adverse events noted in children receiving continuous infusions of dexmedetomidine in the intensive care unit. J Pediatr Pharmacol Ther. 2010 Jan; 15(1):30-7. PMID: 22477790; PMCID: PMC3017405.
    33. Miller JL, Allen C, Johnson PN. Neurologic withdrawal symptoms following abrupt discontinuation of a prolonged dexmedetomidine infusion in a child. J Pediatr Pharmacol Ther. 2010 Jan; 15(1):38-42. PMID: 22477791; PMCID: PMC3017408.
    34. Gish EC, Miller JL, Honey BL, Johnson PN. Lofexidine, an {alpha}2-receptor agonist for opioid detoxification. Ann Pharmacother. 2010 Feb; 44(2):343-51. PMID: 20040696.
      View in: PubMed
    35. Miller JL, Johnson PN, Harrison DL, Hagemann TM. Evaluation of inpatient admissions and potential antimicrobial and analgesic dosing errors in overweight children. Ann Pharmacother. 2010 Jan; 44(1):35-42. PMID: 20028958.
      View in: PubMed
    36. Miller JL, Gormley AK, Johnson PN. Pantoprazole-induced thrombocytopenia. Indian J Pediatr. 2009 Dec; 76(12):1278-9. PMID: 20012806.
      View in: PubMed
    37. Honey BL, Benefield RJ, Miller JL, Johnson PN. Alpha2-receptor agonists for treatment and prevention of iatrogenic opioid abstinence syndrome in critically ill patients. Ann Pharmacother. 2009 Sep; 43(9):1506-11. PMID: 19690220.
      View in: PubMed
    38. Johnson PN, McGoodwin L, Banner W. Utilisation of Crotalidae polyvalent immune fab (ovine) for Viperidae envenomations in children. Emerg Med J. 2008 Dec; 25(12):793-8. PMID: 19033492.
      View in: PubMed
    39. Johnson PN, Kuhn RJ. Combination thrombolytic and anti-platelet therapies in an infant with incomplete kawasaki disease and coronary aneurysms. J Pediatr Pharmacol Ther. 2008 Oct; 13(4):242-50. PMID: 23055883; PMCID: PMC3461989.
    40. Miller JL, Honey BL, Johnson PN, Hagemann TM. Effectiveness of trimethoprim/sulfamethoxazole for children with chronic active otitis media. Pediatrics. 2007 Dec; 120(6):1403; author reply 1403-4. PMID: 18055693.
      View in: PubMed
    41. Johnson PN, Rapp RP, Nelson CT, Butler JS, Overman S, Kuhn RJ. Utilizing Pharmacy Records to Assess Antibiotic Prescribing Patterns on the Incidence of Community-Acquired Methicillin-Resistant Staphylococcus aureus Infections in Children. J Pediatr Pharmacol Ther. 2007 Apr; 12(2):91-101. PMID: 23055846; PMCID: PMC3462095.
    42. Johnson PN, Smith KM. The teaching portfolio: a useful guide for pharmacists' teaching goals. Am J Health Syst Pharm. 2007 Feb 15; 64(4):352, 354, 356. PMID: 17299173.
      View in: PubMed
    43. Johnson PN, Romanelli F, Smith KM, Ranjan D, Butler JS, Clifford TM. Analysis of morbidity in liver transplant recipients following human albumin supplementation: a retrospective pilot study. Prog Transplant. 2006 Sep; 16(3):197-205. PMID: 17007153.
      View in: PubMed
    44. Johnson PN, Smith KM. Low-molecular-weight heparin use in special populations. Orthopedics. 2004 Dec; 27(12):1245-8. PMID: 15633954.
      View in: PubMed
    Johnson's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _